No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Dasatinib
-
Drug Resistance, Neoplasm*
-
Female
-
Fusion Proteins, bcr-abl / antagonists & inhibitors
-
Fusion Proteins, bcr-abl / genetics*
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
-
Middle Aged
-
Mutation / genetics*
-
Protein Kinase Inhibitors / therapeutic use*
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / genetics*
-
Pyrimidines / therapeutic use*
-
Thiazoles / therapeutic use*
-
Treatment Outcome
Substances
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Thiazoles
-
Protein-Tyrosine Kinases
-
Fusion Proteins, bcr-abl
-
Dasatinib